Report Format: PDF
Published Date: Nov-2018 | 200 Pages | Report ID: VSR00381
Global Assisted Reproductive Technology Market Size was valued nearly USD 21.12 billion by 2018 and is estimated to reach up to USD xx.xx billion by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 12.01% during the forecast period that is 2017-2025. Assisted reproductive technology is the technology to achieve conception by surgically removing eggs from a female to combine them with sperms in a laboratory, under specialized conditions, further placing them in ovaries of the female or in ovaries of surrogate mother. The assisted reproductive technology market is gaining traction, due to rising infertility issues among women, coupled with its efficacy in preserving the genetic connection of child with the biological parents.
Global Market Growth Opportunities (Revenue, Growth) By 2017-2025
This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global assisted reproductive technology market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global assisted reproductive technology market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.
Market Dynamics:
Global Assisted Reproductive Technology Market Size showed crucial growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ xx.xx over the forecast period. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 12.01% during the forecast period that is 2017-2025.
The assisted reproductive technology market is anticipated to grow during the forecast period due to increased infertility incidents, owing to reasons like increased alcohol consumption, smoking, obesity, and stress. According to the National Institutes of Mental Health, approximately 1 out of 75 people experience panic disorder and mental issues. The growing acceptance of this technology by various population, coupled with advancements made in the sector in recent years, is further expected to boost the global assisted reproductive technology market. However, social stigma attached with these technologies, coupled with high treatment costs can restrain the growth of assisted reproductive technology market in developing countries. For instance, the cost of IVF in India normally ranges between $1,400 to $5,500 per treatment cycle.
Segment Analysis
Technology Insight: Among various technologies available, in-vitro fertilization-embryo transfer method is expected to hold a major share in the revenue generation, due to its higher success rates, ease of procedure, reimbursement policies and availability of a number of IVF centers and fertility clinics. According to CDC’s (Centers for Disease Control and Prevention) Fertility Clinic Success Rates report in 2016, total 263,577 ART cycles were performed at 463 reporting clinics in the U.S. (in 2016), out of which 65,996 resulted in live births (deliveries of one or more living infants) and 76,930 resulted in live born infants.
Procedure Insight: In the procedure segment, fresh non-donor segment is expected to grow significantly due to their efficacy to retain the genetic connection between the child and biological parents. According to Center for Disease Control and Prevention (CDC), fresh non-donor procedure was the highest used procedure in ART in 2015, which accounted for 39.3% of the total performed assisted reproductive technology cycles. Frozen non-donor segment was the second most used procedure, accounted for 30.1% of the total ART cycles.
End-Use Insights: Hospitals and fertility clinics are the widely segmented end-users of assisted reproductive technology market. Among these two, specialized fertility clinics are expected to be holding the major revenue share in the global assisted reproductive technology market, due to global rise in number of fertility clinics. Presence of fertility clinics like GATJC Fertlity Center, IVF Spain and Embryolab ensures the future growth of fertility clinics in the treatment of assisted reproductive technology market.
Regional Analysis
The global assisted reproductive technology market is divided into regions that are North America - U.S, Canada, Other) (Asia-Pacific -India, Japan, China, Australia, Other) (Europe - UK, Russia, France, Brazil, Other) (Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. North America and Europe are expected to hold major revenue share in the global assisted reproductive technology market, owing to the presence of advanced medical infrastructure in this region. According to CDC, approximately 1.5 million IVF cycles is performed per year globally, out of which 55% of the reported IVF cycles are performed in Europe. The increasing awareness of consumers, along with high disposable incomes of people in these regions will further drive the regional markets.
Global Assisted Reproductive Technology Market Size, Share Analysis By Region 2017
Asia Pacific is expected to show significant market growth in the forecast period, due to increased social acceptance of ART in the region, coupled with increase in infertility cases among countries like India and South Korea and Japan. According to Open Government Data Platform (OGD), total fertility rate (TFR) declined in India by 22.73% from 2.7 in 2005-06 to 2.2 in 2015-16. Middle East and Africa held the largest share of the global market in 2018 and will expand at the highest CAGR during the forecast years.
Global Assisted Reproductive Technology Market Study Objective
1. To forecast the market size of assisted reproductive technology market, along with describing and defining the market, in terms of volume and revenue.
2. Market analysis and forecast of assisted reproductive technology market on the basis of region, substrate and application or end-use industry.
3. To analyze and elaborate significant factors that will have major impact on the growth of assisted reproductive technology market, such as drivers, restraints, challenges and opportunities.
4. Regional analysis of assisted reproductive technology market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.
5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.
6. To provide detailed analysis of competitive and strategic developments in the assisted reproductive technology market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.
7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.
8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.
Key Players Landscape
Key market players operating in assisted reproductive technology market include Nidacon International AB, Merck, Parallabs, Laboratoire CCD, CooperSurgical, Inc., Esco Micro Private Limited, Hamilton Thorne, Inc., Cosmos Biomedical Limited, Bloom IVF Center, Ferring Pharmaceuticals, Irvine Scientific, and Nikon Corporation. On 28 January, 2018, UAE healthcare giant NMC Health completely acquired Fakih IVF to expand their business. In February 2017, Instituto Valenciano de Infertilidad (IVI), announced their entrance in the USA by signing an agreement with Reproductive Medicine Associates of New Jersey (RMANJ).
Global Assisted Reproductive Technology Market Study Report Offer You!
The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.
Save Your Time
Cost-Effective Services
Wide Range of Reports
World Class Market Research
100% Customer Satisfaction
24/7 Customer care Support
Get in touch with us quickly and easily. We are happy to help!
Feel free to contact us anytime using our contact form.
Let's Talk Online